In 2024, the Amyotrophic Lateral Sclerosis Treatment market reached a valuation of USD 674.90 million, with projections indicating a compound annual growth rate (CAGR) of 6.30% from 2025 to 2032. This upward trajectory reflects not just increased diagnosis rates, but also a deeper global commitment to tackling one of the most challenging neurological diseases.
Topics
